C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2002
10/24/2002	US20020156268 Methods for removing dimethoxytrityl groups from oligonucleotides
10/24/2002	US20020156267 High affinity, low molecular weight displacers for oligonucleotide purification
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156246 15625 receptor, a novel G-protein coupled receptor
10/24/2002	US20020156244 Adipocyte complement related protein zacrp13
10/24/2002	US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/24/2002	US20020156004 Polypeptides having significant homology to the prolactin receptor protein
10/24/2002	US20020155989 Protein nucleic acid molecules
10/24/2002	US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/24/2002	US20020155588 Very large scale immobilized polymer synthesis
10/24/2002	US20020155586 Apparatus for monitoring eukaryotic and prokaryotic cell activity
10/24/2002	US20020155543 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders
10/24/2002	US20020155531 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/24/2002	US20020155519 Human blood bacterium
10/24/2002	US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002	US20020155492 Arrays for detecting nucleic acids
10/24/2002	US20020155491 Arrays for detecting nucleic acids
10/24/2002	US20020155484 Oligonucleotide for use as tool in the detection of preferential compounds in solution
10/24/2002	US20020155477 Gene detection system, gene detection device comprising same, detection method, and gene detecting chip
10/24/2002	US20020155468 Ovarian tumor antigen and methods of use therefor
10/24/2002	US20020155462 Generating genetically engineered nucleotide sequences; obtain nucleic acid, incubate with nanoparticles, join sequences and nanoparticles, recover and detect adjustment insequences
10/24/2002	US20020155461 Detecting genetically engineered nucleotide sequences; obtain nucleotide seqences, incubate nanoparticles, recover adjusted nucleotide sequences
10/24/2002	US20020155459 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/24/2002	US20020155458 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/24/2002	US20020155443 Metal compound for use as tool in alkylation, cleavage, metalization, hydrolysis, or crosslinking; for use in treatment of cancer
10/24/2002	US20020155442 Detecting nanoparticle linked nucleotide sequences; obtain nucleotide sequences, incubate with oligonucleotides, detect hybridization
10/24/2002	CA2444624A1 Vascular endothelial growth factor 2
10/24/2002	CA2444467A1 Gradient resolved hybridisation platform
10/24/2002	CA2443903A1 Antibodies to vla-1
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	CA2443122A1 Mobility-modified nucleobase polymers and methods of using same
10/23/2002	EP1251183A2 Improved helper probes for detection of a target sequence by a capture oligonucleotide
10/23/2002	EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases
10/23/2002	EP1251173A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2002	EP1251170A2 Method and reagent for treatment of NF-kappaB dependent animal diseases
10/23/2002	EP1250460A2 Informative nucleic acid arrays and methods for making same
10/23/2002	EP1250423A2 Pullulanase variants and methods for preparing such variants with predetermined properties
10/23/2002	EP1250348A1 Antisense modulation of daxx expression
10/23/2002	EP1250347A1 Antisense modulation of akt-3 expression
10/23/2002	EP1250344A2 Compound comprising a nucleic acid moiety and an organo-silane moiety
10/23/2002	EP0766745B1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/23/2002	CN1376161A Novel bicyclonucleoside analogues
10/23/2002	CN1375503A Androgen receptor compound relative protein
10/23/2002	CN1375277A Prevention of skin chromatosis with tyrosinase antesense oligodeoxynucleotide
10/23/2002	CN1093135C Immobilzied template guided oligonucleotide synthesis method
10/22/2002	US6469157 Using a column containing an immobilized solid support that is functionalized for polynucleotide synthesis
10/22/2002	US6468991 Method of treating rhinoviral infections
10/22/2002	US6468983 RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/22/2002	US6468753 Anthraquinone and its derivatives
10/22/2002	US6468744 Analysis of genetic polymorphisms and gene copy number
10/22/2002	US6468742 Detecting the hybridization of the reporter oligonucleotide to the target nucleic acid
10/22/2002	US6468741 Electrochemiluminescent rhenium moieties
10/22/2002	US6468740 Cyclic and substituted immobilized molecular synthesis
10/22/2002	CA2218477C Rna photocleavage using texaphyrins
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/22/2002	CA2147989C Enhancement of xenograft tolerance and porcine cytokines therefor
10/22/2002	CA1341395C Preparation of functional human factor viii
10/17/2002	WO2002081753A1 Method for identifying and characterizing individual dna molecules
10/17/2002	WO2002081750A1 Method of diagnosing and treating pneumonia and pneumonia-related sepsis associated with the il6-174 gene polymorphism
10/17/2002	WO2002081704A2 Regulation of human protein kinase-like protein
10/17/2002	WO2002081671A1 Novel human kinase and polynucleotides encoding the same
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002081490A2 Computer-directed assembly of a polynucleotide encoding a target polypeptide
10/17/2002	WO2002081476A1 Thiophosphate nucleic acid-based compounds
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002048164A3 Isolation of nucleic acids
10/17/2002	WO2002036804A3 Method for detecting hematopoietic stem cells
10/17/2002	WO2002008420A3 A method of down-regulating gene expression
10/17/2002	WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002	WO2001055370A9 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
10/17/2002	US20020151711 Nucleotide compounds including a rigid linker
10/17/2002	US20020151708 DNA encoding proteins that inhibit Hsp70 function
10/17/2002	US20020151694 Release of intracellular material
10/17/2002	US20020151512 Used to diagnose or treat cancer, restenosis, a disease caused by a virus, a disease affected by integrins or cell-cell adhesion receptor or a disease triggered by diffusible factors
10/17/2002	US20020151511 Antisense oligonucleotide modulation of human MDM2 expression
10/17/2002	US20020151479 Nucleic acids, proteins, and antibodies
10/17/2002	US20020151460 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/17/2002	US20020151072 Chimeric mutational vectors
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020150989 Human tumor necrosis factor receptor
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002	US20020150943 Genotyping by mass spectrometric analysis of allelic fragments
10/17/2002	US20020150931 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder
10/17/2002	US20020150927 Methods for detecting a plurality of analytes by mass spectrometry
10/17/2002	US20020150922 Compositions and methods for the therapy and diagnosis of colon cancer
10/17/2002	US20020150917 Determining concentration of preferential nucleotide sequences in sample; obtain nucleotide sequences, amplify, hybridize with amplicons, detect and quantitate hybridization products
10/17/2002	US20020150905 Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150536 Nucleic acid ligands to integrins
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443319A1 Novel human kinase and polynucleotides encoding the same
10/17/2002	CA2442092A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	CA2433463A1 Computer-directed assembly of a polynucleotide encoding a target polypeptide
10/16/2002	EP1248859A1 Method for synthesising and immobilising nucleic acids on a silanized solid support
10/16/2002	EP1248853A2 Liquid array technology

1 ... 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 ... 899